Neurodegenerative diseases such as Alzheimer's and Parkinson's are widely associated with the buildup of misfolded proteins. Cells have evolved intricate systems of protein quality control (PQC) that serve to monitor the cell for aberrant proteins and target them for degradation, ameloriating the effects of the majority of folding failures. In recent years, Ubr1, an E3 ligase conserved from yeast to humans, has been demonstrated to be involved in the degradation of several misfolded substrates within the cytosol through the Arg/N-end rule pathway, but the significance of this activity was not completely understood. Through a systematic examination of P2-residue variants of model misfolded substrates, followed by global and targeted analyses of yeast proteins, we have determined that Ubr1 is specifically programmed to preferentially target mistranslocated secretory and mitochondrial proteins in the cytosol. Significantly, this newfound specialized functionality may shed light on how Ubr1 and the N-end rule pathway are at play in the onset of neurodegenerative diseases in humans. 
Protein quality control (PQC) is an essential protein quality surveillance and degradation system through which cells ensure the integrity of the proteome and maintain cellular homeostasis ( . San1p targets substrates with exposed hydrophobicity consisting of contiguous sequences of at least five or more hydrophobic residues (Fredrickson et al., 2011 (Fredrickson et al., , 2013 Fredrickson and Gardner 2012) . It was demonstrated that a Ubr1 CytoQC substrate was recognized through an N-end rule pathway N-degron (Kim et al., 2014) . Two other model misfolded substrates, Ste6*C and ∆2GFP, are degraded through a combination of the two pathways. Efficient degradation of each substrate requires both San1p and Ubr1p E3 ligases with differing dependencies: the degradation of Ste6*C is biased towards the Ubr1 pathway, whereas the degradation of ∆2GFP is biased towards the San1 pathway (Figures 1A-B ; Tran, 2013; Prasad et al., 2012; Prasad et al., 2010) . Experiments performed by us at the National University of Singapore were the first to reveal that a leading methionine followed by specific amino acids at the P2 position could enable efficient degradation of misfolded substrates by Ubr1, as demonstrated by mutating the P2 residues of the misfolded substrates ( Figures 1C-1E , 2A, S1A, S1B; Tran, 2013) . These findings were later corroborated in work published by the Varshavsky Lab at the California Institute of Technology in 2014, which formally defined Met-Φ sequences (Φ: bulky hydrophobic residues) as an official class of N-end rule pathway N-degrons (Kim et al, 2014 ). In addition, our work also characterized additionals set of N-degrons that existed: 1) a leading Met residue followed by His, Lys, Arg, or Gln and 2) N-terminal Val and Gly residues, presumably after initiating-Met cleavage. Those original findings are presented here along with figures and captions adapted from the original work.
In the previously cited thesis work, nine amino acids at the P2 position resulted in significant inhibition of Ubr1-mediated degradation of Ste6*C in ∆san1+UBR1 cells: Ala, Asn, Ser, Cys, Glu, Pro, Asp, Thr, and Met, which we refer to as Ubr1-QC-incompatible P2 amino acids His, Trp, Phe, Tyr, Ile, Val, Gln, Gly, Lys, Leu, and Arg, allowed rapid degradation by Ubr1, which we refer to as Ubr1-QC-compatible P2 amino acids (Figure 2A, S2A-S2C ). The same effect was not seen in +SAN1∆ubr1 cells (Figure 2A, S2D-S2F) . The Ubr1-dependent degradation of the 9 most rapidly degraded Ste6*C P2 mutants was confirmed in ∆san1∆ubr1 cells ( Figure S3) . Ste6*C P2 mutants inhibited for Ubr1 degradation was not a result of Ubr1 blockage by Nterminal acetylation since Ste6*C is encoded with a P3 Pro, which prevents N-terminal acetylation (Polevoda and Sherman, 2003) . Leading methionine retention is not a prerequisite for compatibility with the Ubr1-QC degradation pathway, as Ste6*C-I2V was demonstrated to be degraded efficiently by Ubr1 and is predicted to undergo methionine cleavage, which was also confirmed via sequencing ( Figure S1C ).
Interestingly, P2 His, Lys, Gln, and Arg, all of which cause retention of initiating methionines, are not predicted to produce N-termini with known N-degrons of the N-end rule pathway (Kim et al, 2014) . Likewise, P2 Gly and Val residues, which lead to the cleavage of leading methionines and become exposed have also not been identified as N-degrons. Thus, our experiments demonstrate that P2 His, Lys, Gln, Arg, Gly, and Val residues generate novel N-terminal Ndegrons recognized by Ubr1. These differences suggest that there are context and substrate specific influences on the N-end rule pathway's activity in CytoQC.
The majority of secretory pathway and mitochondrially-localized proteins encode Ubr1-QC-compatible P2 residues
To determine if there is a bias within specific cellular compartments for proteins to possess P2 residues that are Ubr1-QC-compatible, we utilized data from a genome-wide GFP-fusion based localization study of protein localization spanning 4156 proteins ( Tables S9  and S10 ). Pair-wise chi-square analysis of individual amino acid usage frequencies demonstrated that biases were seen for the mitochondrial and secretory proteins to be encoded with P2 residues that are Ubr1-QC-compatible, with 6 Ubr1-QC-compatible P2 amino acids (Trp, Phe, Ile, Lys, Leu, and Arg) having statistically significant higher percentage usage frequencies in at least one or both of the mitochondrial and secretory pathway protein sets when compared with cytosolic proteins. An equally important finding is that we observed a significant usage bias against 7 amino acids that do not enable efficient Ubr1 degradation (Ubr1-QC-incompatible P2 residues Ala, Ser, Cys, Glu, Pro, Asp, Thr) in either one or both mitochondrial and secretory pathway protein sets when compared to cytosolic proteins. In contrast, frequency distribution between nuclear and cytosolic proteins had a much less significant difference (nuclear, n=639; cytosolic n = 823; p > 0.001, x 2 = 36.33, df = 19), and only a few significant differences in relative frequencies of individual amino acids. No general bias for or against Ubr1-QC P2 compatibility was observed between the two groups ( Figure 2E ; Table S10 ).
We determined the total relative abundance of proteins within each localization category based on abundance level data gathered from the global yeast protein GFP-fusion study conducted by Huh and colleagues (refer to Materials and Methods). The majority of nuclear and cytosolically localized protein is encoded with Ubr1-QC-incompatible P2 amino acids (84.7% and 70.9%, respectively), while the majority of secretory and mitochondrial protein is associated with Ubr1-QC-compatible P2 amino acids (59.7% and 82.3%, respectively) ( Figure 2F ; Table S17-S27).
The much higher prevalence of Ubr1-QC-compatible proteins in the latter two categories indicated that Ubr1p may be optimized for the degradation of secretory and mitochondrial protein. That they do not natively reside in the cytosol suggested a model in which proteins in these pathways are subject to Ubr1-mediated CytoQC when they fail to translocate. Compartment-specific chaperones and enzymes are important for the native folding processes of secretory and mitochondrial proteins (Hartl et al., 2011; Haynes and Ron, 2010; Stevens and Argon, 1999) . Spontaneous folding by mitochondrial proteins in the cytosol has been shown to occur, thereby preventing import (Strobel, 2002) . Various cytosolic chaperones are designed to maintain pre-translocated proteins in partially-folded, import-competent states, while the folding efficiency of signal-sequence carrying precursor proteins has been to shown to be significantly lower than for that of their mature, signal-sequence cleaved counterparts (Neupert,1997; Laminet and Pluckthun, 1989 ). Thus, a translocation failure of mitochondrial and secretory proteins should theoretically generate conditions optimal for recognition and degradation by Ubr1p: availability of an uncleaved N-terminal sequence containing an N-degron accompanied by impaired or inhibited folding.
Mis-translocated secretory and mitochondrial proteins are degraded by the N-end rule pathway
To test the above hypothesis, we examined ATP2Δ1,2,3, a translocation-defective mutant of Atp2p that is import-deficient and degraded in the cytosol (Bedwell et al., 1987) . ATP2Δ1,2,3 carries a Ubr1-QC-compatible P2 Val residue. Degradation was dependent on a combination of San1 and Ubr1 ( Figure 3A) . We substituted the P2 Val with Ser and observed an inhibition of Ubr1-mediated degradation ( Figure 3B ). The P3 Leu residue was mutated to Pro to inhibit acetylation (Polevoda and Sherman, 2003) . Both forms of the substrate were stabilized to similar levels in Δsan1Δubr1 cells. Degradation was also dependent on Sse1, Ydj1, and Ssa1 and Ssa2 chaperones ( Figure S4 ), hallmarks of UPS-dependent CytoQC. Degradation of wild-type Atp2p in a temperature sensitive mitochondrial-import mutant, tom40-2, was dependent on Ubr1 (Krimmer et al., 2001 ) ( Figure S5 ). These results confirm that translocation-deficient Atp2p is an endogenous substrate of Ubr1-mediated CytoQC.
To determine if translocation-defective secretory pathway proteins are also subject to Ubr1 CytoQC, we generated an import-impaired mutant of vacuolar carboxypeptidase Y (CPY), CPY12iE, which has a P2 Lys. Since any mature, vacuole-processed CPY-12iE would prevent accurate analysis of its pre-form levels, we utilized the fact that C-terminal processing of CPY-HA results in HA tag removal upon maturation ( Figure S6 ). Degradation of pre-CPY-12iE was significantly reduced by the absence of Ubr1p ( Figure 3C , Δsan1+UBR1 vs Δsan1Δubr1). The degradation of endogenous pre-forms of GAS1 and CPY proteins in ER-import deficient strain sec63-1 was dependent on Ubr1, demonstrating that Ubr1 is required for the efficient degradation of a subset of mis-translocated endogenous secretory proteins (unpublished work). GAS1 is also encoded with a Ubr1-QC-compatible P2 residue, Leu.
To assess the significance of substrate misfoldedness to Ubr1-recognition of a misfolded substrate via a Ubr1-QC-compatible P2, we examined wild-type GFP, which is expected to escape CytoQC-based degradation. The P2 Ser of GFP was substituted with Ile to generate GFP-S2I. GFP-S2I was significantly less susceptible to Ubr1 compared to ∆2GFP-S2I, which was degraded efficiently by Ubr1 ( Figure 3F ). Trypsin digestion confirmed the relative structural stability of GFP-S2I when compared to ∆2GFP-S2I ( Figure 3G ). These results indicate that degradation of a substrate via the N-end rule pathway is significantly enhanced when the substrate is also misfolded. This may be a result of the N-terminus of a folding-compromised substrate being aberrantly exposed, making binding by Ubr1p binding more likely. This is similar to the model of protein quality control proposed for proteins possessing Ac/N-degrons. (Shemorry et al., 2013; Hwang et al., 2010) . Alternatively, it may be due to an increased availability of a misfolded substrate's polyubiquitination-competent lysine residues, as one of the requirements of Ubr1-dependent degradation is access to a lysine in an unstructured region of the substrate (Varshavsky, 2011) .
P2 residues act as cellular location signals that mediate CytoQC via the N-end rule pathway
Studies have shown that mislocalized membrane proteins in the cytosol are targeted for degradation through exposed hydrophobic patches in both yeast and mammalian a cells ( . If mistranslocated proteins without Ubr1-QC-compatible P2 residues are primarily membrane proteins, most would be degradable through these pathways and rendered benign. To assess whether Ubr1 N-end rule based CytoQC, along with quality control pathways targeting hydrophobicity, could together provide an effective degradation system for clearing the cytosol of mis-localized proteins, we analyzed a set of 277 ORFs encoding signal sequencecontaining proteins used in a previous study to determine the frequency of amino acids encoded at the P2 position in secretory proteins (Forte et al., 2011) . This set was filtered for duplicates and other inconsistencies, resulting in 273 proteins which were then categorized as soluble or membrane proteins (refer to Materials and Methods). Strikingly, 87.5% (49/56) of ER proteins encoded with Ubr1-QC-incompatible residues are membrane proteins, strongly differing from the full set of signal-sequence bearing proteins, for which only 64.1% (173/270) are membrane proteins (p < 0.001, x 2 = 11.7) ( Figure 4B ; Tables S12-S16 ). An even larger difference was observed when compared to the relative frequency of membrane proteins in the set of Ubr1-QCcompatible P2-residue-encoded proteins (57.9% (124/214); p < 5 x 10 -5 , x 2 = 16.8). These results indicate that the vast majority of ER proteins which are not compatible with Ubr1 are also, at a higher relative frequency, membrane proteins, which is expected to allow their degradation through pathways that target exposed hydrophobicity, such as San1-mediated CytoQC.
Interestingly, statistically significant differences were seen in the relative frequency of proteins encoding Ubr1-QC-compatible P2 residues when comparing the set of soluble proteins with membrane proteins (Chi-square test: p < 5 x 10 -5 , x 2 = 16.8), as well as with the full set of signalsequence bearing proteins (p < 0.005, x 2 = 9.7): 92.8% (90/97) of the soluble protein set possess Ubr1-QC-compatible P2 residues, versus 78.8% (215/273) of the full set of signal-sequence bearing proteins, and only 71.7% (124/173) of the membrane proteins. (Figure 4A ; Table S12-S16). Thus, while the majority of signal-sequence bearing proteins are susceptible to Ubr1, soluble secretory proteins are particularly suited for degradation through this pathway. In contrast, only ~26.6% of cytosolic proteins possess Ubr1-QC-compatible P2 residues based on an analysis of a representative set of 251 randomly selected cytosolic proteins ( Figure 4A ; Table  S11 ; Forte et al., 2011) . This minority of cytosolic proteins with Ubr1-QC-compatible P2 residues are expected to fold efficiently in their native environment, thereby escaping targeting by Ubr1 CytoQC, as demonstrated in pulse-chase experiments involving folded vs misfolded GFP ( Figure 3F ).
The findings presented here broaden our understanding of how eukaryotic cells ensure the the cytosol is kept in a healthy state mostly clear of foreign actors that could disrupt normal cellular processes such as signaling, protein synthesis, and trafficking. Failures in SRP-mediated ER targeting causes the mistargeting of secretory proteins to the mitochondria, resulting in mitochondrial dysfunction (Costa et al., 2018) , while depletion of nascent polypeptide-associated complex (NAC) results in the incorrect import of mitochondrial proteins into the ER lumen (Gamerdinger et al., 2015) . Such aberrant cross-organelle mis-targeting might also be mitigated by the Ubr1 CytoQC pathway, capturing such proteins in the cytosol before mis-targeting is able to occur. We propose that there is an intrinsic pressure for secretory and mitochondrial proteins to be encoded with Ubr1-QC-compatible P2 residues so they can be efficiently degraded in the event of mislocalization as a result of translocation failure. Soluble ER proteins in particular are preferentially targeted by Ubr1. That they would not be recognized by hydrophobicity-based degradation pathways due to their lack of transmembrane domains, and possession of only moderately hydrophobic signal sequences, necessitates Ubr1-QC-compatibility to be efficiently cleared from the cytosol. Together, our findings also suggest that P2 residues are utilized as de facto cellular location signals which help to ensure the the fidelity of protein localization. This system of P2-encoded location signaling facilitates N-end rule pathway-mediated degradation of the majority of soluble mislocalized proteins in the cytosol. Whether mislocalized P2-residue-dependent Ubr1 substrates are engaged by the cytosolic form of Ubr1, or are first trafficked to the nucleus and subsequently recognized by the the nuclear form of Ubr1, remains to be determined. Interestingly, herpes simplex virus 1-encoded microRNA has been shown promote the accumulation of β-amyloid through the inhibition of Ubr1 activity (Zheng et al., 2018 ). An intriguing avenue of research would be to investigate if the P2-residue based degradation of mis-localized proteins by Ubr1 described here is mirrored in mammalian cells, and if so, whether it is involved in preventing the accumulation of neurodegenerative disease factors such as β-amyloid.
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FIGURES MATERIALS AND METHODS
Note: All non-bioinformatic biological experimental methods described here are excerpted from the original thesis work performed by Anthony Tran at National University of Singapore for his doctoral dissertation (Tran, 2013) . The original thesis work was performed in the lab of Associate Professor Davis Ng at the National University of Singapore.
Yeast strains used in this study are listed in Table S28 . Anti-HA monoclonal antibody (HA.11) was sourced from Covance (Princeton, New Jersey). Monoclonal anti-3-phosphoglycerate kinase (PGK) was sourced from Invitrogen (Carslbad, California). Anti-CPY antibody was a gift from Reid Gilmore (University of Massachusetts, Worcester, MA). Anti-Gas1p antibody was raised against amino acids 40 to 289 of Gas1p (Davis Ng, NUS/TLL).
Plasmids and primers
Standard cloning procedures were utilized for the construction of plasmids (Sambrook, et al., 1989). Unless otherwise stated, exogenously expressed substrates possess an engineered single hemagglutinin (HA) epitope tag attached to the C-terminus. Ste6*C, Δ2GFP , ATP2Δ1,2,3, and their derivatives, were expressed under control of a high expression, constitutive TDH3 (glyceraldehyde-3-phosphate dehydrogenase) promoter in yeast centromeric plasmids. HAtagged Prc1p (CPY/carboxypeptidase Y) and its derivatives were placed under control of its native constitutive endogenous promoter in yeast centromeric plasmids. Site-directed mutagenesis of the original constructs expressing Ste6*C, Δ2GFP, and ATP2Δ1,2,3 was performed to generate mutant substrates.
pAT1: A fragment carrying the PRC1 promoter was PCR amplified from pSW119 with BamHI and NotI restriction ends. The amplified fragment and pSW119 were digested with NotI and BamHI and ligated to generate pAT1. pAT32: A fragment encoding the TDH3 promoter, followed by Ste6*C-HA, followed by the ACT1 terminator sequence, was PCR amplified from pRP22 with primers AT270 and AT273 and digested with NotI and XhoI. The fragment was then ligated into an empty pRS316 vector to generate pAT32. pAT33-pAT51: pAT33 through pAT51 (expressing Ste6*C-I2K, Ste6*C-I2Y, Ste6*C-I2F, Ste6*C-I2A, Ste6*C-I2L, Ste6*C-I2E, Ste6*C-I2V, Ste6*C-I2G, Ste6*C-I2R, Ste6*C-I2M, Ste6*C-I2P, Ste6*C-I2W, Ste6*C-I2N, Ste6*C-I2D, Ste6*C-I2H, Ste6*C-I2Q, Ste6*C-I2C, Ste6*C-I2T, Ste6*C-I2S) were constructed by mutation of the base-pairs encoding the 2nd residue of Ste6*C through site-directed mutagenesis using primers AT21-AT39 and pRP22 as a template. pAT52: A fragment encoding residues 1201-1290 of the STE6 ORF followed by a hemagglutinin epitope (HA-tag) sequence was PCR amplified from yeast genomic DNA using primers AT40 and AT41. The fragment was digested with BamHI and XbaI and ligated to pRP22 digested with BamHI and XbaI generating pAT52. pAT55-pAT57: pAT55 through pAT57 (expressing Δ2GFP-S2I, Δ2GFP-S2F, Δ2GFP-S2K) were constructed by mutation of the base-pairs encoding the 2nd residue of Δ2GFP through sitedirected mutagenesis using primers AT18-AT20 and pRP44 as a template. pAT61: A 741bp fragment of the GFP ORF followed by the hemagglutinin (HA) tag sequence was PCR amplified using mutational primers AT189 and AT190 and pAT7 as a template. The resultant PCR product carrying the GFP ORF with the 2nd residue mutated to an isoleucine was digested with BamHI and XbaI and ligated to pAT7 digested with BamHI and XbaI generating pAT61. pAT64: A 1563-bp fragment carrying the ATP2 ORF followed by the hemagglutinin epitope (HA-tag) sequence was PCR amplified from yeast genomic DNA using primers AT244 and AT226. The fragment was digested with BglII and XbaI and ligated to pAT7 digested with BamHI and XbaI generating pAT64. pAT65: pAT66 was digested with ClaI and XhoI to release a 2671-bp fragment encoding the TDH3 promoter, ATP2Δ1,2,3-HA, and ACT1 terminator sequences. This fragment was ligated into an empty pRS316 vector digested with ClaI and XhoI to generate pAT65. pAT66: A 1506-bp fragment carrying the ATP2 ORF with deletions of residues 5-12, 16-19, and 28-34, followed by the hemagglutinin epitope (HA-tag) sequence was PCR amplified from yeast genomic DNA using primers AT246 and AT226. The fragment was digested with BglII and XbaI and ligated to pAT7 digested with BamHI and XbaI generating pAT66. pAT68: pAT68 (expressing ATP2Δ1,2,3-V2S,L3P-HA) was constructed by mutation of the sequences encoding the 2nd and 3rd residues of ATP2Δ1,2,3-HA, from valine to serine at the P2 position, and leucine to proline at the 3rd position, through site-directed mutagenesis using primer AT275 and pAT66 as a template. pAT72: pAT72 (expressing PRC1-12iE) was constructed by the insertion of a three base-pair sequence encoding a glutamic acid residue at the 12th codon position of the PRC1 ORF through site-directed mutagenesis using primer AT280 and pXW92 as a template.
Metabolic Pulse-Chase Assay
Yeast cells were grown to log phase at 30°C (25°C for temperature sensitive strains). 3 OD 600 units of cells were resuspended in 0.9ml of SC or SC selective media and incubated at 30°C (37°C for temperature sensitive strains) for 30 minutes. Pulse labeling was then initiated with the addition of 82.5 µCi of [35S]Met/Cys (EasyTagTM EXPRESS 35S, PerkinElmer) for 5 or 10 minutes depending on the labeling efficiency of the substrate of interest. Label was chased with the addition of excess cold methionine and cysteine to a final concentration of 2mM. At the appropriate timepoints, pulse labeling/chase was terminated by the addition of 100% TCA to a final concentration of 10%. Immunoprecipitation of samples and resolution by SDS-PAGE were carried out as described (Vashist et al., 2001) . Phosphor screens exposed to gels (1 to 5 day exposure, depending on substrate expression level) were scanned with a Typhoon TM phosphoimager and the visualized bands of interest quantified using ImageQuant TL software (GE Healthcare Life Sciences, Uppsala, Sweden). Background signal from screen exposure was subtracted. All results presented are the mean ± SD of at least three independent experiments.
Trypsin Sensitivity Assay
Yeast cells expressing the substrate of interest were grown to log phase (0.4-0.6 OD) and resuspended in cytosol buffer (20 mM HEPES-KOH, pH 7.4, 14 % glycerol, 100 mM KOAc, and 2 mM MgOAc) at a concentration of 20 OD/mL. 1mL of this resuspension was transferred to a 2ml screw-cap tube and homogenized by vortexing for 30 seconds in the presence of 1ml of 0.5mm diameter zirconium beads followed by a 1 minute incubation at 4°C. This was performed for 5 cycles. The homogenate was transferred to 1.5ml eppendorf tubes. 0.6ml of fresh cytosol buffer was used to wash the beads and pooled with the original homogenate. Post-nuclear lysate was isolated by pelleting at 500xg for 5 minutes and transferring the supernatant to a fresh tube. The post-nuclear lysate was incubated at 30°C for 5 minutes, followed by the addition of trypsin to a concentration of 5µg/ml. Samples were vortexed and incubated for 30°C, with 100ul aliquots taken at the indicated timepoints and mixed with 11.1ul of 100% TCA in fresh 1.5ml eppendorf tubes. Aliquots were kept on ice for 5 minutes and pelleted at 14000rpm for 20 minutes at 4°C. Supernatant was discarded, sample pelleted again briefly, and supernatant again discarded. The pellet was resuspended in 10ul of TCA resuspension buffer (100 mM Tris-HCl pH 11.0, 3 % SDS, 1mM PMSF) by cycles of boiling at 100°C and vortexing. Samples were pelleted at 4°C to remove SDS and other insoluble particles, and the resultant supernatant transferred to a fresh tube. Analysis by SDS-PAGE/Western Blotting was performed using the appropriate antibodies.
Edman Degradation N-terminal Seqeuncing
Yeast cells expressing the protein of interest were grown to 1 OD/mL in selective media. 800OD of yeast cells were harvested at 3000xg for 15 minutes, washed once with 1x PBS, and pelleted again at 3000xg. Cells were washed in IP/NP40/PIC/DTT (50mM Tris-HCl, pH8 150mM NaCl, 0.1% NP-40, 0.1mM DTT), pelleted at 3000xg, and resuspended in IP/NP40/DTT containing protease inhibitors (complete, mini, EDTA-free protease inhibitor cocktail tablet, Roche) at a concentration of 50 OD/ml. 1 mL aliquots of the resuspension were transferred to a 2ml screwcap tubes and homogenized by beadbeating for 30 seconds using a Mini-BeadBeater cell disrupter (Biospec Products) followed by a 5 minute incubation on ice; beadbeating and incubation on ice was repeated for 6 cycles in the presence of 1ml of 0.5mm diameter zirconium beads. The homogenate was transferred to 1.5ml eppendorf tube. 0.6ml of fresh cytosol buffer was used to wash the beads and pooled with the original homogenate. Lysate was cleared by centrifugation at 14000 rpm and transferred to a fresh tube. Lysate was incubated with 65uL of Roche Anti-HA affinity matrix per 4mL of lysate for 2 hours or overnight at 4°C. Affinity matrix was spun down at 2700rpm for 1 minute and washed with ice cold IP/NP40/PIC/DTT three times, followed by one wash with cold IP buffer to remove residual NP40. Bound proteins were eluted from matrix through the addition of protein loading buffer (PLB) and subsequent boiling at 100°C for 10 minutes. Immunoprecipitated proteins were resolved on 12% SDS-PAGE gels and transferred to a PVDF membrane. Membrane was washed with dIH2O for 1 minute (3 x 1 minute, shaking at 70rpm) to eliminate traces of SDS, Tris, glycine, and other reagents that have the potential to interfere with Edman chemistry. The membrane was then stained with Coomassie Brilliant Blue (0.1% CBB, 5% acetic acid, 50% methanol) for 5 minutes by shaking at 70rpm. Membrane was quickly destained with 50% methanol (3 x 1 minute, shaking at 70rpm). Band containing the protein of interest was excised from the membrane and cut into smaller pieces to facilitate sample analysis. Membrane fragments were loaded into an ABI Procise 494 Sequencer for sequencing using standard manufacturer recommended protocols.
Bioinformatic analysis
The raw data file containing protein translations for systematically-named ORFs was obtained from Saccharomyces Genome Databse (SGD) . To facilitate parsing with PHP, quotation marks in protein descriptions were removed, and a termination character ("@") was added to the end of the file.
(http://downloads.yeastgenome.org/sequence/S288C_reference/orf_protein/; orf_trans.fasta.gz) A PHP script was written to extract from this data file the systematic name of each ORF and the first 2 residues in its respective protein sequence, and subsequently output into an SQL database; a list of 5887 ORFS and their N-terminal sequence were produced (Table S1 ). The list of proteins exclusively localized to each of the main protein localization categories (nuclear, mitochondrial, cytoplasmic, or secretory) was determined based on complete or partial localization to that category, as determined by the localization terms assigned to each protein through a GFP-fusion localization method (Huh et al., 2003) . Nuclear proteins included those assigned the following localization terms: nucleus, nucleolous, and nuclear periphery. Secretory proteins included those assigned the following terms: ER, Golgi, vacuole, endosome, and peroxisome. Proteins assigned the term mitochondrion were categorized as mitochondrial. Proteins assigned with the term cytoplasm were categorized as cytosolic. To determine the relative total abundance of proteins with nuclear, cytosolic, secretory, or mitochondrial localization that encode Ubr1-QC-compatible or Ubr1-QC-incompatible P2 residues, we summed the abundance levels of proteins in each subset as quantified in the GFP-localization study (Huh et al. 2003) , and divided it by the aggregate abundance of all proteins within the full localization category (Table S17-S27) .
Categorization of signal-sequence bearing proteins
A published set of 277 signal-sequencing bearing proteins was analyzed (Table S12 ; Forte et al., 2011) . Two of this original set were duplicate entries (AIM6/YDL237W duplicate of LRC1, FLO11/YIR019C duplicate of MUC1) and were not included in the analysis. Two were not present in the YeastSGD database and were also excluded (YCR012C, and YJL052C) (Table  S13) . After these exclusions, a manual review was performed on each protein to identify literature that supported soluble or membranous topology. 211 of the proteins were successfully categorized through the review of literature (Tables S14-S16, S14A, S15A). For 59 proteins for which supporting literature could not be found, protein sequences of each were analyzed with SignalP 4.1 using the default optimized parameters. Proteins that were not predicted to possess a signal sequence cleavage site were categorized as membrane proteins. To assess the topology of proteins that were predicted to possess a signal sequence cleavage site, Kyte-Doolittle hydropathy profiles were obtained, and membrane prediction with Phobius performed. KyteDoolittle analysis was performed with a window size of 19. Proteins with a hydrophobicity score of greater than 1.8 after the predicted cleavage site were categorized as membrane proteins. Proteins that did not have a hydrophobicity score of greater than 1.8 after the predicted cleavage site were categorized as soluble proteins. 3 proteins which did not have consensus between KyteDoolittle and Phobius analysis were excluded from relative frequency calculations involving topology.
DATA AVAILABILITY
The data that support the findings of this study are available from the corresponding author upon reasonable request, or are included in the supplemental tables provided. Figure S1 . N-terminal sequencing of Ste6*C constructs. (A) Lysate was prepared from ∆san1∆ubr1 cells expressing Ste6*C-HA. Protein was immunoprecipitated from lysate with anti-HA affinity matrix (Roche), resolved by SDS-PAGE, and transferred to PVDF membrane. Protein band carrying Ste6*C-HA was excised from the membrane and sequenced via Edman degradation. (B) Lysate was prepared from ∆san1∆ubr1 cells expressing Ste6*C-HA-I2S. Protein was immunoprecipitated from lysate and sequenced as described in Figure S1A . (C) Lysate was prepared from ∆san1∆ubr1 cells expressing Ste6*C-HA-I2V. Protein was immunoprecipitated from lysate and sequenced as described in Figure S1A . (A) Turnover rates of N-terminally destabilized Ste6*C-I2X mutants in ∆san1∆ubr1 cells were assessed by pulse-chase analysis as described in Figure 1A . Degradation of Ste6*C-I2I in ∆san1+UBR1 cells was also examined as a control. Error bars, mean +/-SD of three independent experiments. (B) Heat map reflecting turnover rates of Ste6*C-I2X substrates in ∆san1∆ubr1 as presented in S3A. Figure S4 . Degradation of ATP2∆1,2,3 is dependent on chaperones involved in CytoQC degradation. Turnover of ATP2∆1,2,3 in WT, ∆ydj1, ∆sse1∆sse2, and ∆ssa1 cells was analyzed by pulse-chase as described in in 5A. Student's t-test: *, p < 0.05; **, p < 0.01; ***, p < 0.005; Not Significant (NS), p > 0.5. Error bars, mean +/-SD of at least three independent experiments. Figure S5 . Wild-type Atp2p is degraded by Ubr1p in mitochondrial import mutant strain tom40-2. HA-tagged wild-type ATP2 protein expressed in TOM40 (wild-type), tom40-2, and tom40-2∆ubr1 cells was analyzed by pulse-chase analysis as described in Figure 1A . Error bars, mean +/-SD of at least three independent experiments. Figure S6 . C-terminal HA-tag is removed from HA-tagged CPY in the vacuole. Pulse-chase analysis of CPY-HA was performed in ∆prc1, ∆pep4, ∆san1+UBR1, and ∆san1∆ubr1 cells as described in Figure  1A . CPY was probed with anti-CPY and anti-HA antibodies in ∆prc1 cells, and anti-HA in ∆pep4 cells. Error bars, mean +/-SD of at least three independent experiments.
